(Q37551919)

21 August 2017

1 reference

title

Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin (English)

1 reference

21 August 2017

1 reference

Teni Boulikas

1

1 reference

PubMed ID

19604121

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

1 reference

21 August 2017

18

1 reference

21 August 2017

8

1 reference

21 August 2017

1197-1218

1 reference

The discovery of antiangiogenic molecules: a historical review

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Histone deacetylation : an attractive target for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Targeting poly (ADP) ribose polymerase I (PARP-1) and PARP-1 interacting proteins for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Role of copper transporters in resistance to platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Platinum transporters and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Organic cation transporters are determinants of oxaliplatin cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Activity of lipoplatin in tumor and in normal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Taxane-platinum combinations in advanced non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

How to stabilize phospholipid liposomes (using nanoparticles).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

Paclitaxel: a hope for advanced non-small cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

DNA methylation: A promising target for the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903114168

10.1517/13543780903114168

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19604121